D. Koulenti, E. Tsigou, and J. Rello, Nosocomial pneumonia in 27 ICUs in Europe: perspectives from the EU-VAP/CAP study, Eur J Clin Microbiol Infect Dis, vol.36, issue.11, pp.1999-2006, 2017.

D. Koulenti, T. Lisboa, C. Brun-buisson, W. Krueger, A. Macor et al., Spectrum of practice in the diagnosis of nosocomial pneumonia in patients requiring mechanical ventilation in European intensive care units, Crit Care Med, vol.37, issue.8, pp.2360-2369, 2009.

A. C. Kalil, M. L. Metersky, M. Klompas, J. Muscedere, D. A. Sweeney et al., Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia, p.2016

, Clinical Practice Guidelines by the Infectious Diseases Society of America and the, Clin Infect Dis, vol.63, issue.5, pp.61-111, 2016.

J. Almirall, I. Bolíbar, J. Vidal, G. Sauca, P. Coll et al., Epidemiology of community-acquired pneumonia in adults: a population-based study, Eur Respir J, vol.15, issue.4, pp.757-63, 2000.

N. Safdar, C. Dezfulian, H. R. Collard, and S. Saint, Clinical and economic consequences of ventilator-associated pneumonia: a systematic review, Crit Care Med, vol.33, issue.10, pp.2184-93, 2005.

A. Combes, C. Luyt, J. Fagon, M. Wolff, J. Trouillet et al., Early predictors for infection recurrence and death in patients with ventilator-associated pneumonia, Crit Care Med, vol.35, issue.1, pp.146-54, 2007.

J. Garnacho-montero, J. L. Garcia-garmendia, A. Barrero-almodovar, F. J. Jimenez-jimenez, C. Perez-paredes et al., Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis*, Crit Care Med, vol.31, issue.12, pp.2742-51, 2003.

M. Ioanas, M. Ferrer, M. Cavalcanti, R. Ferrer, S. Ewig et al., Causes and predictors of nonresponse to treatment of intensive care unit-acquired pneumonia*, Crit Care Med. avr, vol.32, issue.4, pp.938-983, 2004.

A. A. Domínguez, M. V. Arango, and A. Torres, Treatment Failure in Patients with VentilatorAssociated Pneumonia, Semin Respir Crit Care Med, vol.27, issue.01, pp.104-118, 2006.

G. Gursel, M. Aydogdu, E. Ozyilmaz, and T. N. Ozis, Risk factors for treatment failure in patients with ventilator-associated pneumonia receiving appropriate antibiotic therapy, J Crit Care, vol.23, issue.1, pp.34-40, 2008.

C. Carrie, M. Bentejac, V. Cottenceau, F. Masson, L. Petit et al., Association between augmented renal clearance and clinical failure of antibiotic treatment in brain-injured patients with ventilator-acquired pneumonia: A preliminary study, Anaesth Crit Care Pain Med, vol.37, issue.1, pp.35-41, 2018.

M. Bassetti, J. G. Montero, and J. A. Paiva, When antibiotic treatment fails, Intensive Care Med. janv, vol.44, issue.1, pp.73-78, 2018.
DOI : 10.1007/s00134-017-4962-2

URL : https://link.springer.com/content/pdf/10.1007%2Fs00134-017-4962-2.pdf

E. Meyer, F. Schwab, and P. Gastmeier, Nosocomial methicillin resistant staphylococcus aureus pneumonia -epidemiology and trends based on data of a network of 586 German ICUs, 2005.

, Eur J Med Res, vol.15, issue.12, p.514, 2010.

, Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia, Am J Respir Crit Care Med, vol.171, issue.4, pp.388-416, 2005.

C. Carrie, M. Bentejac, V. Cottenceau, F. Masson, L. Petit et al., Association between augmented renal clearance and clinical failure of antibiotic treatment in brain-injured patients with ventilator-acquired pneumonia: A preliminary study, Anaesth Crit Care Pain Med, vol.37, issue.1, pp.35-41, 2018.

D. Lepelletier, A. Roquilly, D. Dit-latte, D. Mahe, P. J. Loutrel et al., Retrospective Analysis of the Risk Factors and Pathogens Associated With Early-onset Ventilator-associated Pneumonia in Surgical-ICU Head-trauma Patients, J Neurosurg Anesthesiol, vol.22, issue.1, pp.32-39, 2010.

M. Fekih-hassen, B. Haj-khalifa, A. Tilouche, N. , B. Sik-ali et al., Pneumopathies communautaires sévères en réanimation : caractéristiques cliniques, bactériologiques et facteurs pronostiques : une expérience tunisienne, Rev Pneumol Clin, vol.70, issue.5, pp.253-262, 2014.

O. Leroy, C. Vandenbussche, C. Coffinier, C. Bosquet, H. Georges et al., Community-acquired Aspiration Pneumonia in Intensive Care Units: Epidemiological and Prognosis Data, Am J Respir Crit Care Med. déc, vol.156, issue.6, pp.1922-1931, 1997.

A. Torres, J. Serra-batlles, A. Ferrer, P. Jiménez, R. Celis et al., Severe Communityacquired Pneumonia: Epidemiology and Prognostic Factors, Am Rev Respir Dis, vol.144, issue.2, pp.312-320, 1991.

D. Benhamou, A. S. Carrié, and F. Lecomte, Staphylococcus aureus : place et impact dans la prise en charge des pneumopathies nosocomiales, Rev Mal Respir. sept, vol.22, issue.4, pp.595-603, 2005.

D. L. George, P. S. Falk, R. G. Wunderink, K. V. Leeper, G. U. Meduri et al., Epidemiology of Ventilator-acquired Pneumonia Based on Protected Bronchoscopic Sampling, Am J Respir Crit Care Med. déc, vol.158, issue.6, pp.1839-1886, 1998.

C. Watanakunakorn, Bacteremic Staphylococcus aureus pneumonia, Scand J Infect Dis, vol.19, issue.6, pp.623-630, 1987.

W. Campbell, E. Hendrix, R. Schwalbe, A. Fattom, and R. Edelman, Head-injured patients who are nasal carriers of Staphylococcus aureus are at high risk for Staphylococcus aureus pneumonia, Crit Care Med, vol.27, issue.4, pp.798-801, 1999.

F. Espersen and J. Gabrielsen, Pneumonia due to Staphylococcus aureus during mechanical ventilation, J Infect Dis, vol.144, issue.1, pp.19-23, 1981.
DOI : 10.1093/infdis/144.1.19

, Étude et enquête surveillance des infections nosocomiales en réanimation adultes -Réseau REA-Raisin, 2015.

Z. Athanassa, I. I. Siempos, and M. E. Falagas, Impact of methicillin resistance on mortality in Staphylococcus aureus VAP: a systematic review, Eur Respir J. 1 mars, vol.31, issue.3, pp.625-657, 2008.

W. G. Melsen, M. M. Rovers, and M. Bonten, Ventilator-associated pneumonia and mortality: A systematic review of observational studies*: Crit Care Med, vol.37, pp.2709-2727, 2009.

D. Myny, P. Depuydt, F. Colardyn, and S. Blot, Ventilator-associated pneumonia in a tertiary care unit : analysis of risk factors for acquisition and mortality, Acta Clin Belg, vol.60, issue.3, pp.114-135, 2005.

M. D. Rincon-ferrari, J. M. Flores-cordero, S. R. Leal-noval, F. Murillo-cabezas, A. Cayuelas et al., Impact of Ventilator-Associated Pneumonia in Patients with Severe Head Injury, J Trauma Inj Infect Crit Care, vol.57, issue.6, pp.1234-1274, 2004.

N. Bercault and T. Boulain, Mortality rate attributable to ventilator-associated nosocomial pneumonia in an adult intensive care unit: a prospective case-control study, Crit Care Med, vol.29, issue.12, pp.2303-2312, 2001.

R. J. Boots, J. Lipman, R. Bellomo, D. Stephens, and R. F. Heller, Disease risk and mortality prediction in intensive care patients with pneumonia. Australian and New Zealand practice in intensive care (ANZPIC II), Anaesth Intensive Care, vol.33, issue.1, pp.101-112, 2005.

J. Zahar, C. Clec'h, M. Tafflet, M. Garrouste-orgeas, S. Jamali et al., Is Methicillin Resistance Associated with a Worse Prognosis in Staphylococcus aureus Ventilator-Associated Pneumonia?, Clin Infect Dis, vol.41, issue.9, pp.1224-1255, 2005.

K. Agbaht, E. Diaz, E. Muñoz, T. Lisboa, F. Gomez et al., Bacteremia in patients with ventilator-associated pneumonia is associated with increased mortality: A study comparing bacteremic vs. nonbacteremic ventilator-associated pneumonia*: Crit Care Med, vol.35, pp.2064-70, 2007.

J. Quincampoix and J. Mainardi, Mécanismes de résistance des cocci à Gram positifMechanisms underlying resistance of Gram-positive bacteria, Réanimation, vol.10, issue.3, pp.267-75, 2001.

C. Ryffel, F. H. Kayser, and B. Berger-bächi, Correlation between regulation of mecA transcription and expression of methicillin resistance in staphylococci, Antimicrob Agents Chemother, vol.36, issue.1, pp.25-31, 1992.

G. Wang, J. F. Hindler, K. W. Ward, and D. A. Bruckner, Increased Vancomycin MICs for Staphylococcus aureus Clinical Isolates from a University Hospital during a 5-Year Period, J Clin Microbiol, vol.44, issue.11, pp.3883-3889, 2006.

H. F. Chambers and F. R. Deleo, Waves of resistance: Staphylococcus aureus in the antibiotic era, Nat Rev Microbiol, vol.7, issue.9, pp.629-670, 2009.

Y. Gillet, B. Issartel, P. Vanhems, J. Fournet, L. G. Bes et al., Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients, The Lancet, vol.359, issue.9308, pp.753-762, 2002.

D. A. Caroff, L. Li, J. Muscedere, and M. Klompas, Subglottic Secretion Drainage and Objective Outcomes: A Systematic Review and Meta-Analysis, Crit Care Med, vol.1, 2015.

L. Lorente, M. Lecuona, A. Jiménez, L. Lorenzo, I. Roca et al., Continuous endotracheal tube cuff pressure control system protects against ventilator-associated pneumonia, Crit Care, vol.18, issue.2, p.77, 2014.

L. Holzapfel, C. Chastang, G. Demingeon, J. Bohe, B. Piralla et al., A Randomized Study Assessing the Systematic Search for Maxillary Sinusitis in Nasotracheally Mechanically Ventilated Patients: Influence of Nosocomial Maxillary Sinusitis on the Occurrence of Ventilator-associated Pneumonia, Am J Respir Crit Care Med, vol.159, issue.3, pp.695-701, 1999.

L. Cabrini, G. Landoni, A. Oriani, V. P. Plumari, L. Nobile et al., Noninvasive Ventilation and Survival in Acute Care Settings: A Comprehensive Systematic Review and Metaanalysis of Randomized Controlled Trials*, Crit Care Med. avr, vol.43, issue.4, pp.880-888, 2015.

J. Quenot, S. Ladoire, F. Devoucoux, J. Doise, R. Cailliod et al., Effect of a nurse-implemented sedation protocol on the incidence of ventilator-associated pneumonia, Crit Care Med, vol.35, issue.9, pp.2031-2037, 2007.

G. S. Doig, P. T. Heighes, F. Simpson, E. A. Sweetman, and A. R. Davies, Early enteral nutrition, provided within 24 h of injury or intensive care unit admission, significantly reduces mortality in critically ill patients: a meta-analysis of randomised controlled trials, Intensive Care Med, vol.35, issue.12, pp.2018-2045, 2009.

R. Blaser, A. Starkopf, J. Alhazzani, W. Berger, M. M. Casaer et al., Early enteral nutrition in critically ill patients: ESICM clinical practice guidelines, ESICM Working Group on Gastrointestinal Function, vol.43, pp.380-98, 2017.

. Sfar, Pneumonies associées aux soins de réanimation RFE commune SFAR SRLF, 2017.

S. Sroka, P. Gastmeier, and E. Meyer, Impact of alcohol hand-rub use on meticillin-resistant Staphylococcus aureus: an analysis of the literature, J Hosp Infect. mars, vol.74, issue.3, pp.204-215, 2010.

C. Pileggi, A. Bianco, D. Flotta, C. G. Nobile, and M. Pavia, Prevention of ventilator-associated pneumonia, mortality and all intensive care unit acquired infections by topically applied antimicrobial or antiseptic agents: a meta-analysis of randomized controlled trials in intensive care units, Crit Care, vol.15, issue.3, p.155, 2011.

S. Kõljalg, P. Naaber, and M. Mikelsaar, Antibiotic resistance as an indicator of bacterial chlorhexidine susceptibility, J Hosp Infect, vol.51, issue.2, pp.106-119, 2002.

G. Ridenour, R. Lampen, J. Federspiel, S. Kritchevsky, E. Wong et al., Selective Use of Intranasal Mupirocin and Chlorhexidine Bathing and the Incidence of Methicillin-Resistant Staphylococcus aureus Colonization and Infection Among Intensive Care Unit Patients, Infect Control Hosp Epidemiol, vol.28, issue.10, pp.1155-61, 2007.

K. B. Laupland and J. M. Conly, Treatment of Staphylococcus aureus Colonization and Prophylaxis for Infection with Topical Intranasal Mupirocin: An Evidence-Based Review, Clin Infect Dis, vol.37, issue.7, pp.933-941, 2003.

C. Brun-buisson, A. Rauss, P. Legrand, H. Mentec, M. Ossart et al., Traitement du portage nasal de Staphylococcus aureus par la mupirocine nasale et prévention des infections acquises en réanimation. Etude multicentrique contrôlée, Médecine Mal Infect, vol.24, issue.12, pp.1229-1268, 1994.
DOI : 10.1016/s0399-077x(05)81042-x

, Antibiothérapie par voie générale dans les infections respiratoires basses de l'adulte Pneumonie aiguë communautaire Exacerbations de Bronchopneumopathie Chronique Obstructive Mise au point AFSSAPS, 2010.

, CLSI Performance Standards for Antimicrobial Susceptibility Testing, 2013.

B. H. Gern, A. L. Greninger, S. J. Weissman, J. R. Stapp, Y. Tao et al., Continued in vitro cefazolin susceptibility in methicillin-susceptible Staphylococcus aureus, Ann Clin Microbiol Antimicrob [Internet]. déc, vol.17, issue.1, 2018.

M. Paul, N. Zemer-wassercug, O. Talker, Y. Lishtzinsky, B. Lev et al., Are all beta-lactams similarly effective in the treatment of methicillin-sensitive Staphylococcus aureus bacteraemia?, Clin Microbiol Infect, vol.17, issue.10, pp.1581-1587, 2011.

M. Wynn, J. R. Dalovisio, A. D. Tice, and X. Jiang, Evaluation of the Efficacy and Safety of Outpatient Parenteral Antimicrobial Therapy for Infections With Methicillin-sensitive Staphylococcus aureus, South Med J. juin, vol.98, issue.6, pp.590-595, 2005.

S. A. Zelenitsky, N. P. Beahm, H. Iacovides, R. E. Ariano, and G. Zhanel, Limitations of ceftriaxone compared with cefazolin against MSSA: an integrated pharmacodynamic analysis, J Antimicrob Chemother. 1 juill, vol.73, issue.7, pp.1888-94, 2018.

D. M. Richards, R. N. Brogden, and . Ceftazidime, A review of its antibacterial activity, pharmacokinetic properties and therapeutic use, Drugs. févr, vol.29, issue.2, pp.105-61, 1985.

S. Kim, K. Kim, H. Kim, N. Kim, E. Kim et al., Outcome of Vancomycin Treatment in Patients with Methicillin-Susceptible Staphylococcus aureus Bacteremia, Antimicrob Agents Chemother, vol.52, issue.1, pp.192-199, 2008.

K. G. Blumenthal, R. A. Parker, E. S. Shenoy, and R. P. Walensky, Improving Clinical Outcomes in Patients With Methicillin-Sensitive Staphylococcus aureus Bacteremia and Reported Penicillin Allergy, Clin Infect Dis, vol.61, issue.5, pp.741-750, 2015.
DOI : 10.1093/cid/civ394

URL : https://academic.oup.com/cid/article-pdf/61/5/741/16787653/civ394.pdf

M. L. Schweizer, J. P. Furuno, A. D. Harris, J. K. Johnson, M. D. Shardell et al., Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillinsusceptible Staphylococcus aureus bacteremia, BMC Infect Dis, vol.11, issue.1, 2011.

J. Fu, X. Ye, C. Chen, and S. Chen, The Efficacy and Safety of Linezolid and Glycopeptides in the Treatment of Staphylococcus aureus Infections. van Veen HW, éditeur, PLoS ONE, vol.6, issue.3, p.58240, 2013.

, Place du linézolide dans la prise en charge de pneumonies nosocomiales à Staphylococcus aureus résistants à la méticilline (SARM) -Le Pharmacien Hospitalier et Clinicien, 2014.

J. Kim, J. Chung, S. Choi, H. Jang, S. Hong et al., Early use of imipenem/cilastatin and vancomycin followed by de-escalation versus conventional antimicrobials without de-escalation for patients with hospital-acquired pneumonia in a medical ICU: a randomized clinical trial, Crit Care, vol.16, issue.1, p.28, 2012.

, Thérapeutique des infections à Staphylococcus aureus sensible la méticilline

J. Li, K. L. Echevarria, and K. A. Traugott, ?-Lactam Therapy for Methicillin-Susceptible Staphylococcus aureus Bacteremia: A Comparative Review of Cefazolin versus Antistaphylococcal Penicillins, Pharmacother J Hum Pharmacol Drug Ther, vol.37, issue.3, pp.346-60, 2017.

, Propositions d'alternatives à l'oxacilline ou la cloxacilline par voie IV chez l'adulte et l'enfant en contexte de rupture de stock, SPILF 2017

S. N. Rao, N. J. Rhodes, B. J. Lee, M. H. Scheetz, A. P. Hanson et al., Treatment Outcomes with Cefazolin versus Oxacillin for Deep-Seated Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections, Antimicrob Agents Chemother, vol.59, issue.9, pp.5232-5240, 2015.
DOI : 10.1128/aac.04677-14

URL : https://aac.asm.org/content/59/9/5232.full.pdf

A. D. Bai, A. Showler, L. Burry, M. Steinberg, D. R. Ricciuto et al., Comparative effectiveness of cefazolin versus cloxacillin as definitive antibiotic therapy for MSSA bacteraemia: results from a large multicentre cohort study, J Antimicrob Chemother, vol.70, issue.5, pp.1539-1585, 2015.

J. Li, K. L. Echevarria, D. W. Hughes, J. A. Cadena, J. E. Bowling et al., Comparison of Cefazolin versus Oxacillin for Treatment of Complicated Bacteremia Caused by MethicillinSusceptible Staphylococcus aureus, Antimicrob Agents Chemother, vol.58, issue.9, pp.5117-5141, 2014.

I. Brook, Inoculum effect, Rev Infect Dis, vol.11, issue.3, pp.361-369, 1989.
DOI : 10.1093/clinids/11.3.361

S. E. Luria, A test for penicillin sensitivity and resistance in Staphylococcus, Proc Soc Exp Biol Med Soc Exp Biol Med N Y N, vol.61, pp.46-51, 1946.

, Comité de l'antibiogramme de la société française de microbiologie. European committee on antimicrobial susceptibility testing, 2018.

E. C. Nannini, M. E. Stryjewski, K. V. Singh, A. Bourgogne, T. H. Rude et al., Inoculum Effect with Cefazolin among Clinical Isolates of Methicillin-Susceptible Staphylococcus aureus: Frequency and Possible Cause of Cefazolin Treatment Failure, Antimicrob Agents Chemother, vol.53, issue.8, pp.3437-3478, 2009.

D. J. Livorsi, E. Crispell, S. W. Satola, E. M. Burd, R. Jerris et al., Prevalence of blaZ Gene Types and the Inoculum Effect with Cefazolin among Bloodstream Isolates of Methicillin-Susceptible Staphylococcus aureus, Antimicrob Agents Chemother, vol.56, issue.8, pp.4474-4481, 2012.

D. S. Kernodle, C. W. Stratton, L. W. Mcmurray, J. R. Chipley, and P. A. Mcgraw, Differentiation of beta-lactamase variants of Staphylococcus aureus by substrate hydrolysis profiles, J Infect Dis, vol.159, issue.1, pp.103-111, 1989.

D. J. Zygmunt, C. W. Stratton, and D. S. Kernodle, Characterization of four beta-lactamases produced by Staphylococcus aureus, Antimicrob Agents Chemother, vol.36, issue.2, pp.440-445, 1992.

Y. P. Chong, S. Park, E. S. Kim, K. Bang, M. Kim et al., Prevalence of blaZ gene types and the cefazolin inoculum effect among methicillin-susceptible Staphylococcus aureus blood isolates and their association with multilocus sequence types and clinical outcome, Eur J Clin Microbiol Infect Dis. févr, vol.34, issue.2, pp.349-55, 2015.

S. Rincon, J. Reyes, L. P. Carvajal, N. Rojas, F. Cortes et al., Cefazolin highinoculum effect in methicillin-susceptible Staphylococcus aureus from South American hospitals, J Antimicrob Chemother. 1 déc, vol.68, issue.12, pp.2773-2781, 2013.

E. C. Nannini, K. V. Singh, and B. E. Murray, Relapse of Type A -Lactamase-Producing Staphylococcus aureus Native Valve Endocarditis during Cefazolin Therapy: Revisiting the Issue, Clin Infect Dis, vol.37, issue.9, pp.1194-1202

E. L. Quinn, D. Pohlod, T. Madhavan, K. Burch, E. Fisher et al., Clinical experiences with cefazolin and other cephalosporins in bacterial endocarditis, J Infect Dis, vol.128, pp.386-389, 1973.

R. E. Bryant, Unsuccessful Treatment of Staphylococcal Endocarditis With Cefazolin, JAMA J Am Med Assoc, vol.237, issue.6, p.569, 1977.

S. Lee, K. T. Kwon, H. Kim, H. H. Chang, J. Lee et al., Clinical Implications of Cefazolin Inoculum Effect and ?-Lactamase Type on Methicillin-Susceptible Staphylococcus aureus Bacteremia, Microb Drug Resist. 2014réanimation. Réanimation, vol.14, issue.4, pp.264-75, 2005.

F. Scaglione, S. Esposito, S. Leone, V. Lucini, M. Pannacci et al., Feedback dose alteration significantly affects probability of pathogen eradication in nosocomial pneumonia, Eur Respir J, vol.34, issue.2, pp.394-400, 2009.

F. Jehl and D. Levêque, Perfusion continue des bêtalactamines : intérêts, inconvénients, modalités pratiques, Réanimation, vol.18, issue.4, pp.343-52, 2009.
DOI : 10.1016/j.reaurg.2009.03.009

W. A. Craig, Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men, Clin Infect Dis Off Publ Infect Dis Soc Am, vol.26, issue.1, pp.11-12, 1998.

G. L. Drusano, H. C. Standiford, C. Bustamante, A. Forrest, G. Rivera et al., Multipledose pharmacokinetics of imipenem-cilastatin, Antimicrob Agents Chemother, vol.26, issue.5, pp.715-736, 1984.
DOI : 10.1128/aac.26.5.715

URL : https://aac.asm.org/content/26/5/715.full.pdf

J. A. Roberts, S. K. Paul, M. Akova, M. Bassetti, J. J. De-waele et al., Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?, Clin Infect Dis. 15 avr, vol.58, issue.8, pp.1072-83, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01954093

C. Luyt, N. Bréchot, J. Trouillet, and J. Chastre, Antibiotic stewardship in the intensive care unit, Crit Care, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01313131

J. J. De-waele, J. Lipman, M. Akova, M. Bassetti, G. Dimopoulos et al., Risk factors for target non-attainment during empirical treatment with ?-lactam antibiotics in critically ill patients, Intensive Care Med, vol.40, issue.9, pp.1340-51, 2014.

J. P. Baptista, A. A. Udy, E. Sousa, J. Pimentel, L. Wang et al., A comparison of estimates of glomerular filtration in critically ill patients with augmented renal clearance, Crit Care Lond Engl, vol.15, issue.3, p.139, 2011.

R. Brown, R. Babcock, J. Talbert, J. Gruenberg, C. Czurak et al., Renal function in critically ill postoperative patients: sequential assessment of creatinine osmolar and free water clearance, Crit Care Med, vol.8, issue.2, pp.68-72, 1980.

B. A. Kohl and C. S. Deutschman, The inflammatory response to surgery and trauma, Curr Opin Crit Care, vol.12, issue.4, pp.325-357, 2006.

A. A. Udy, P. Jarrett, M. Lassig-smith, J. Stuart, T. Starr et al., Augmented Renal Clearance in Traumatic Brain Injury: A Single-Center Observational Study of Atrial Natriuretic Peptide, Cardiac Output, and Creatinine Clearance, J Neurotrauma, vol.34, issue.1, pp.137-181, 2017.

A. Udy, R. Boots, S. Senthuran, J. Stuart, R. Deans et al., Augmented Creatinine Clearance in Traumatic Brain Injury, Anesth Analg, vol.111, issue.6, pp.1505-1515, 2010.

A. A. Udy, J. P. Baptista, N. L. Lim, G. M. Joynt, P. Jarrett et al., Augmented Renal Clearance in the ICU: Results of a Multicenter Observational Study of Renal Function in Critically Ill Patients With Normal Plasma Creatinine Concentrations*, Crit Care Med, vol.42, issue.3, pp.520-527, 2014.

B. Claus, E. A. Hoste, K. Colpaert, H. Robays, J. Decruyenaere et al., Augmented renal clearance is a common finding with worse clinical outcome in critically ill patients receiving antimicrobial therapy, J Crit Care, vol.28, issue.5, pp.695-700, 2013.

O. Fuster-lluch, M. Gerónimo-pardo, R. Peyró-garcía, and M. Lizán-garcía, Glomerular hyperfiltration and albuminuria in critically ill patients, Anaesth Intensive Care, vol.36, issue.5, pp.674-80, 2008.

J. P. Baptista and A. A. Udy, Augmented renal clearance in critical illness: « The Elephant in the ICU, Minerva Anestesiol, vol.81, issue.10, pp.1050-1052, 2015.

A. Hobbs, K. M. Shea, K. M. Roberts, and M. J. Daley, Implications of Augmented Renal Clearance on Drug Dosing in Critically Ill Patients: A Focus on Antibiotics, Pharmacother J Hum Pharmacol Drug Ther, vol.35, issue.11, pp.1063-75, 2015.

A. A. Udy, J. A. Roberts, J. J. De-waele, D. L. Paterson, and J. Lipman, What's behind the failure of emerging antibiotics in the critically ill? Understanding the impact of altered pharmacokinetics and augmented renal clearance, Int J Antimicrob Agents, vol.39, issue.6, pp.455-462, 2012.

A. A. Udy, J. M. Varghese, M. Altukroni, S. Briscoe, B. C. Mcwhinney et al.,

, Subtherapeutic Initial ?-Lactam Concentrations in Select Critically Ill Patients, Chest, vol.142, issue.1, pp.30-39, 2012.

A. Huttner, V. Dach, E. Renzoni, A. Huttner, B. D. Affaticati et al., Augmented renal clearance, low ?-lactam concentrations and clinical outcomes in the critically ill: An observational prospective cohort study, Int J Antimicrob Agents, vol.45, issue.4, pp.385-92, 2015.

C. Carrié, L. Petit, N. Houdain, N. Sauvage, V. Cottenceau et al., Association between augmented renal clearance, antibiotic exposure and clinical outcome in critically ill septic patients receiving high doses of ?-lactams administered by continuous infusion: a prospective observational study, Int J Antimicrob Agents, vol.51, issue.3, pp.443-452, 2018.

C. , Are standard doses of cefazolin administered by continuous infusion sufficient for critically ill patients with augmented creatinine clearance?

S. Lee, P. G. Choe, K. Song, S. Park, H. B. Kim et al., Is Cefazolin Inferior to Nafcillin for Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteremia? Antimicrob Agents Chemother, vol.55, pp.5122-5128, 2011.

A. H. Chung and K. Watson, Cefazolin-induced hypoprothrombinemia, Am J Health Syst Pharm. 1 mai, vol.65, issue.9, pp.823-829, 2008.
DOI : 10.2146/ajhp070243

E. Gay, A. Barthel, N. Rouzic, B. Henriot, B. Quélennec et al., Cefazolin and coagulation disorders: a case report, Ann Biol Clin (Paris). janv, issue.1, pp.104-106, 2018.

S. A. Alqahtani, D. E. Kleiner, M. Ghabril, J. Gu, J. H. Hoofnagle et al., Identification and Characterization of Cefazolin-Induced Liver Injury, Clin Gastroenterol Hepatol. juill, vol.13, issue.7, pp.1328-1336, 2015.

J. D. Schwankhaus, E. F. Masucci, and J. F. Kurtzke, Cefazolin-induced encephalopathy in a uremic patient, Ann Neurol. févr, vol.17, issue.2, pp.211-211, 1985.

F. A. Manian, S. Aradhyula, S. Greisnauer, D. Senkel, J. Setzer et al., Is It Clostridium difficile Infection or Something Else? A Case-control Study of 352 Hospitalized Patients With New-onset Diarrhea, South Med J. août, vol.100, issue.8, pp.782-788, 2007.

C. D. Salgado, P. D. Mauldin, P. J. Fogle, and J. A. Bosso, Analysis of an outbreak of Clostridium difficile infection controlled with enhanced infection control measures, Am J Infect Control. août, vol.37, issue.6, pp.458-64, 2009.

, Les pneumopathies acquises sous ventilation mécanique SFAR, 2009.

I. Youngster, E. S. Shenoy, D. C. Hooper, and S. B. Nelson, Comparative Evaluation of the Tolerability of Cefazolin and Nafcillin for Treatment of Methicillin-Susceptible Staphylococcus aureus Infections in the Outpatient Setting, Clin Infect Dis. 1 août, vol.59, issue.3, pp.369-75, 2014.

M. H. Abdul-aziz, H. Sulaiman, M. Mat-nor, V. Rai, K. K. Wong et al., BetaLactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis, Intensive Care Med, vol.42, issue.10, pp.1535-1580, 2016.

L. Stulik, J. Hudcova, D. E. Craven, G. Nagy, and E. Nagy, Low Efficacy of Antibiotics Against Staphylococcus aureus Airway Colonization in Ventilated Patients, Clin Infect Dis. 15 avr, vol.64, issue.8, pp.1081-1089, 2017.

S. W. Chapman and R. T. Steigbigel, Staphylococcal beta-lactamase and efficacy of beta-lactam antibiotics: in vitro and in vivo evaluation, J Infect Dis. juin, vol.147, issue.6, pp.1078-89, 1983.

S. T. Housman, C. A. Sutherland, and D. P. Nicolau, Pharmacodynamic profile of commonly utilised parenteral therapies against meticillin-susceptible and meticillin-resistant Staphylococcus aureus collected from US hospitals, Int J Antimicrob Agents. sept, vol.44, issue.3, pp.235-276, 2014.

J. F. Barletta, A. J. Mangram, M. Byrne, A. K. Hollingworth, J. F. Sucher et al., The importance of empiric antibiotic dosing in critically ill trauma patients: Are we underdosing based on augmented renal clearance and inaccurate renal clearance estimates?, J Trauma Acute Care Surg. déc, vol.81, issue.6, pp.1115-1136, 2016.